不同的视角由专业的Oligometastatic结肠直肠癌:一个韩国Oligometastasis工作组的比较调查研究研究
Won Kyung Cho1, Gyu Sang Yoo1, Chai Hong Rim2
1Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cancer research and treatment
|June 8, 2023
概括
结肠直肠外科医生和放射瘤学家对寡头转移性疾病 (OMD) 管理有不同的看法,特别是在转移部位和分子诊断方面. 弥合这些观点是多学科共识在OMD治疗的关键.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 辐射瘤学 辐射瘤学
背景情况:
- 氧基质扩散性疾病 (OMD) 缺乏普遍认可的定义和治疗策略.
- 为了优化OMD管理,跨学科的共识至关重要.
研究的目的:
- 调查和分析结直肠外科医生和放射瘤学家关于结直肠癌引起的OMD的定义和治疗的不同意见.
- 确定这些专业之间主要的共识和分歧领域.
主要方法:
- 一项基于调查的研究涉及141名参与者:63名放射瘤学家和78名结直肠外科医生.
- 分析了对19个调查问题的答案,使用千-平方测试来确定各专业之间的统计差异.
主要成果:
- 放射性瘤学家比外科医生 (19.2%) 更倾向于骨转移 (36.5%),而外科医生则比瘤学家 (9.5%) 更倾向于腹膜播种 (26.9%).
- 结肠直肠外科医生认为,如果局部可治疗 (48.3%),转移性瘤的数量无关紧要,比放射瘤学家 (21.8%) 更多.
- 在分子诊断的感知重要性中观察到一个显著的差异,74.8%的外科医生同意,而瘤学家的比例为35.8%.
结论:
- 虽然在诊断成像,生物标志物,全身疗法和OMD的时间方面存在共识,但结直肠外科医生和放射瘤学家之间的观点仍然存在显著差异.
- 了解这些不同的观点对于开发一种统一的多学科方法来定义和管理OMD至关重要.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


